The abortifacient effects of a newly developed vaginal silastic device impregnated with an 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester in the first trimester.

Source:http://linkedlifedata.com/resource/pubmed/id/1277841

Download in:

View as

General Info

PMID
1277841